Christine Lagarde: There Needs to Be Global Regulation of BTC

ECB President Christine Lagarde has expressed her thoughts on BTC in a recent interview, claiming the asset needs to be regulated on a “global level.” Christine Lagarde: Bitcoin Must Be Globally Regulated In her opinion, bitcoin has given people open doorways to numerous financial crimes such as money laundering. Thus, without global regulation in play, these doors can never be […]

Read more

Bitcoin Replacing Gold Is a ‘Real Possibility’, Says Veteran Investor Todd Horwitz

Veteran trader Todd Horwitz has revealed that while he doesn’t believe bitcoin will replace gold as the de-facto store of value, he says it’s a “real possibility” as central bank intervention in the financial markets has been pushing investors toward crypto. Horwitz’s words came during an interview with Kitco News, first spotted by Daily Hodl, where he both discussed the […]

Read more

Swiss Stock Exchange SIX Lists New Bitcoin ETF

Swiss stock exchange SIX has revealed the listing of a new Bitcoin exchange-traded product (ETP) from financial firm ETC Group. This was announced on Wednesday, 13th of January in a press release by the stock exchange. Physically backed ETP According to the press release, the newly released product by ETC called BTCE tracks the price of Bitcoin and is 100% […]

Read more

Ledger Launches Bounty Fund Of 10 BTC Following Data Breach

Hardware wallet producer Ledger has been under heat for the breach of its database which led to the disclosure of over 270,000 of its customers’ data. After an investigation, the company has traced the possible culprit via Shopify, the e-commerce platform responsible for managing Ledger’s hardware wallet sales. Following the discovery, the company has launched a bounty to fish out […]

Read more

Stock Alert: KB Home Adds 6% Following Upbeat Results

Shares of homebuilding company KB Home (KBH) are rising more than 6% Wednesday morning after the company’s fourth-quarter earnings beat estimates. Net income in the fourth quarter was $106.1 million or $1.12 per share compared with $123.2 million or $1.31 per share in the same quarter a year ago. On average, 7 analysts polled by Thomson Reuters expected the company […]

Read more

Will 2021 Continue To Be An Exciting Year For Relmada Therapeutics?

We are hardly two weeks into 2021, and shares of Relmada Therapeutics Inc. (RLMD) have gained 22% so far this year. Relmada is a late-stage biotech company developing drugs to treat diseases of the central nervous system in an entirely new way. The lead drug candidate is REL-1017, a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels […]

Read more
1 185 186 187 188 189 192